Share 'Sarepta and their push for Accelerated Approval of Eteplirsen'
I do not understand why this information is not here on this site, but people should be aware of Sarepta's push with the FDA to gain accelerated approval of their drug, eteplirsen, designed to skip exon 51.
Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes
Eteplirsen Manufacturing and Clinical Ac…
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this